Anzemet
Company: Hoechst Marion Roussel
Approval Status: Approved September 1997
Treatment for: Treatment for chemotherapy induced emesis
Areas: Oncology
Possible similar drugs: Anzemet
General Information
Other Useful Resources
Anzemet has been approved for the prevention of chemotherapy-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
